Insights from the molecular analyses of the fragile X mental retardation 1 gene (FMR1) and the expansion of its unstable trinucleotide repeat to cause fragile X syndrome are touchstones in the genetics of non-Mendelian traits and the neuroscience of mental retardation. Fragile X syndrome, one of the more common forms of inherited mental retardation, is typically caused by expansion of the CGG repeat in the 5 0 untranslated region of FMR1. Based on length of the CGG tract, there are three categories of FMR1 alleles in the population: normal alleles with 5 to 54 repeats, fully penetrant mutant alleles of more than 200 repeats that suppress FMR1 transcription, leading to a loss of function, and premutation alleles between 55 and 200 CGG repeats. Premutation alleles, precursors to mutant alleles as they expand into full mutations during maternal germline transmission, were historically thought to have no effect on the phenotype of carriers. Given the long history of following fragile X families, one of the more remarkable findings in human genetics is the recent association of the neurodegenerative disorder fragile X-associated tremor/ ataxia syndrome (FXTAS) among carriers of FMR1 premutations (Hagerman and Hagerman 2004) . FMR1 premutation alleles uniquely produce FMR1 RNA with an elongated CGG (rCGG) repeat tract, leading to the hypothesis that premutant transcripts cause the neurodegenerative disease in carriers. Two points are worth mentioning with regard to FXTAS: first, there is no overlap in phenotype between FRAXA and FXTAS; second, FXTAS, unlike FRAXA, is not fully penetrant in males. Previously, Jin et al. (2003) showed in Drosophila that FMR1 premutation RNA causes neurodegeneration, providing the first direct evidence that FMR1 RNA may mediate neurodegeneration in premutation carriers. Similar to the pathogenesis of myotonic dystrophy (Ranum and Cooper, 2006) , two papers in this issue of Neuron provide data supporting a mechanism in FXTAS where the functions of RNA-binding proteins are compromised by binding to the FMR1 rCGG repeats in premutation alleles Sofola et al., 2007) .
Both studies rely on the Drosophila model of FXTAS that expresses 90 repeats from the 5 0 UTR of human FMR1 and is characterized by neuronal degeneration of photoreceptors (Jin et al., 2003) . Taking a biochemical approach, Jin et al. (2007) isolated potential rCGG repeat-binding proteins from mouse cerebellar lysates and identified them by mass spectroscopy. Of the five proteins characterized by this approach, three were identified as tropomyosin and two RNA-binding proteins, hnRNP A2/B1 (one gene, two splice variants) and Pur a. Since Pur a knockout mice have a neurodegenerative phenotype (Khalili et al., 2003) , this group focused on it. On the other hand, Sofola et al. (2007) took a genetic tack and identified CUGBP1, the RNA-binding protein implicated in DM, as also having a role in FXTAS. This group performed a genetic screen in Drosophila, using a collection of flies with mutations in 60 different candidate RNA-binding proteins. A mutation in only one of these genes modified the neurodegenerative eye phenotype of the FXTAS fly, CUGBP1. They also examined whether the other RNA-binding protein implicated in DM, the muscleblind-like protein 1 (MBNL1), is involved in the rCGG-induced neurodegeneration and found no evidence for a genetic interaction. This indicates that MBNL1 is unlikely to have a role in FXTAS in the fly.
At this point, both groups examined the interaction of their respective proteins with rCGG repeats. Jin et al. showed that Pur a binds directly to rCCG repeats. As its name implies, and as demonstrated previously (Timchenko et al., 1996) , Sofola et al. (2007) found that CUGBP1 does not interact directly with rCGG repeats. Taking a cue from Jin et al. (2007) , they found that endogenous CUGBP1 and hnRNP A2 coimmunoprecipitate from mouse brain lysates. In contrast, CUGBP1 and Pur a do not coimmunoprecipitate. Using a gel-shift assay, Sofola et al. (2007) confirmed that hnRNP A2/B1 interacts directly with rCGG repeats. These results provide rather convincing data in support of the existence of two distinct rCGG: protein complexes, one involving hnRNP A2/B1 and CUGBP1 and a second complex with Pur a.
Could both rCGG complexes be relevant to FXTAS pathogenesis? To address this crucial question, each group determined whether overexpressing the RNA-binding protein had an effect on rCGG-mediated neurodegeneration in the fly. In both instances, overexpression of Pur a and hnRNP A2/B1 (Sofola et al., 2007) suppressed the rCGG-mediated neurodegenerative phenotype. These findings provide good evidence that each RNA-binding protein has a role in the pathogenesis of FXTAS (Figure 1 ).
Yet the stories for hnRNP A2/B1 and Pur a are not without complications. HnRNP A2/B1 are highly abundant, predominantly nuclear proteins reported to be involved in several aspects of RNA processing, including RNA packaging and splicing, cytoplasmic RNA trafficking, and cap-dependent translation (e.g., Dreyfuss et al., 1993; Kwon et al., 1999) . While both normal and premutant repeat rCGG tracts bound to cytoplasmic hnRNP A2/B1, Sofola et al. (2007) were unable to detect an interaction of rCGG repeats with hmRNP A2/B1 in the nuclear fraction. They speculate that perhaps hnRNP A2/B1 undergoes some compartment-specific modification, such as phosphorylation, that alters binding. Like hnRNP A2/B1, Pur a is a widely expressed singlestranded DNA and RNA binding protein that prefers to bind to purine-rich sequences and has been implicated in many processes, including regulation of transcription and translation (Khalili et al., 2003) . Yet, rCGG pathogenic repeats fold, at least in vitro, into double-stranded RNA hairpins just like rCUG repeats in DM (Sobczak et al., 2003) ; so perhaps these proteins bind to rCGG repeats in a futile effort to unravel these potentially toxic hairpins and in the process neglect their other cellular functions. Of significance is the observation that Pur a null mice are normal at birth but quickly develop tremor and gait abnormalities (Khalili et al., 2003) , reminiscent of FXTAS. Jin et al. (2007) utilized immunohistochemistry to localize Pur a to the ubiquitin-positive nuclear inclusions in neurons in a FXTAS brain. This finding contrasts with a previous study that used a mass spectrometry approach and did not find Pur a in FXTAS inclusions (Iwahashi et al., 2006) . Thus, the physical nature of the rCGG-Pur a interaction is unclear.
Together these two studies take us one important step further in suggesting that FXTAS pathogenesis is mechanistically related to the DMs, thus increasing the likelihood that RNAbased pathogenesis is not unique to DM. The seminal question now becomes what are the downstream target RNAs of CUGBP1/hnRNP A2/B1 and Pur a, how is their processing altered by the rCGG repeat, and how do these processing mistakes lead to FXTAS. If FXTAS continues to follow the DM model, presumably the processing of specific mRNAs is impacted, which is crucial for developing the FXTAS neurological phenotype. It is intriguing that FMR1 mRNA, which encodes an RNA-binding protein that functions in the regulation of mRNA translation (Garber et al., 2006) , itself contains an element that can affect the functions of other RNA-binding proteins (Figure 1 ). Whether the interaction of rCGG repeats with hnRNP A2/B1 and/or Pur a have a role in the normal biology of these proteins remains to be determined. The function of inwardly rectifying K + (Kir) channels is highly diverse and therefore is tightly regulated by various environmental factors. In their article in this issue of Neuron, Rapedius et al. recognize a conserved structural mechanism for Kir channels gating by both pH and PIP 2 . In light of these findings and accumulated knowledge, PIP 2 is suggested to have a common coregulatory role in the gating of Kir channels by all their soluble modulators.
Inwardly-rectifying K + (Kir) channels are an important class of K + channels involved in the regulation of membrane excitability, heart rate, vascular tone, hormone secretion, and in the control of body salt balance (Bichet et al., 2003) . Kir channel activity was shown to be affected by several factors, including pH, Na + and Mg 2+ ions, ATP, polyamines, G proteins, and phosphatidylinositol-4,5-bisphosphate (PIP 2 ) (Reimann and Ashcroft, 1999) . Current model for Kir channel gating claims that conformational rearrangements in the cytoplasmatic domains, promoted by environmental factors or ligand binding, are transduced to the transmembrane domains (TMs), which in turn rotate to allow opening of the channel pore (Bichet et al., 2003) .
For any biological system with convergent regulation by multiple factors, questions can be asked about mutual and hierarchical interactions among these factors and the specific role each contributes to the overall modulation. Indeed, in the case of Kir channel regulation, several studies were aimed at revealing the relevance of multiple interactions among the currently known modulators to channel gating. For example, both G protein and Na + ions were shown to stabilize GIRK(Kir3.x)-PIP 2 interaction (Huang et al., 1998) . Similarly, in K ATP (Kir6.x) channels, binding of PIP 2 reduces the channel sensitivity to ATP inhibition (Baukrowitz et al., 1998) . Furthermore, the notable structural resemblance among Kir channels as opposed to the diverse type of chemical entities that modulate the channels implies that the final step in the cascade of channel regulation may involve a specific mediator, common to all channels. Understanding the biochemical and structural basis underlying channel modulation may clarify the nature of the complex regulation of Kir channels. Yet, highly tuned and reliable techniques are required to provide the desired temporal resolution, which would allow distinctive characterization of the different stages of channel activation and modulation. In this issue of Neuron, Rapedius et al. (2007) provide new insights into a conserved mechanism of Kir channel gating to establish that both low pH and PIP 2 act through a common downstream element that controls the stabilization of the closed or open channel conformations, respectively (Rapedius et al., 2007) . Using two independent kinetic measurement methodologies, the authors were able to establish that the rate-limiting step in channel activation is not the binding or unbinding of PIP 2 but the conformational rearrangement that follows PIP 2 binding. The latter event is much slower and can be dramatically enhanced by the disruption of a hydrogen bond between the 3-nitrogen of K80 located in TM1 and the carbonyl oxygen of A177 located in TM2, suggesting that this TM1-TM2 hydrogen bond stabilizes the closed state of the channel and its rupture may be one of the rate-limiting steps in channel transition between the closed to the open conformations. Interestingly, this mechanism of stabilization of the closed state was also found in other members of the IR channel family, hence suggesting a general conserved mechanistic basis for the closed-channel conformation. PIP 2 , the main modulator for channel activation, is the one involved in disrupting this hydrogen bond to support channel activation or stabilization of the open conformation. In addition, Rapedius et al. (2007) provide
